Bruker price target raised to $49 from $43 at UBS

UBS raised the firm’s price target on Bruker (BRKR) to $49 from $43 and keeps a Neutral rating on the shares. The FY26 guidance leaves questions on ramp dynamics, the analyst tells investors in a research note.